Results 251 to 260 of about 3,368,671 (295)

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto   +12 more
wiley   +1 more source

Cardiometabolic medication exposures and cognitive outcomes in Alzheimer's disease. [PDF]

open access: yesAge Ageing
Wang Y   +5 more
europepmc   +1 more source

[Comments by Cicero MD to Santillán MD].

open access: yesRevista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 2007
openaire   +1 more source

Minimally invasive vs standard open carpal tunnel release: A systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials. [PDF]

open access: yesJPRAS Open
Almarri AK   +14 more
europepmc   +1 more source

Same-day discharge does not increase complications or readmissions in carefully selected patients undergoing aseptic lower extremity nonunion surgery. [PDF]

open access: yesOTA Int
Lauck BJ   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy